January 28, 2019 by Chain Drug Review
Shopko, Walgreens, Walgreens Boots Alliance
Business, Leading Headlines, Pharmacy, Retail News
NEW YORK – Walgreens Boots Alliance was the big winner in the auction for the pharmacy assets of bankrupt retailer Shopko, taking charge of about half the assets that were on sale. Agreements are in various stages that get Walgreens the assets (including prescription inventories, records, customer lists and patient profiles) from 60 of the about 120 pharmacies
December 20, 2018 by Chain Drug Review
FedEx and Humana, Kroger, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) on Thursday reported first quarter double-digit earnings growth for fiscal 2019 that beat analysts’ expectations, while revenue fell short of forecasts. The retailer’s revenue was $33.79 billion. “We are pleased to have delivered double-digit percentage growth in earnings per share in the first quarter, including solid results in
November 13, 2018 by Chain Drug Review
Credit Suisse 27th Annual Healthcare Conference, James Kehoe, Walgreens Boots Alliance
Leading Headlines, Retail News
DEERFIELD, Ill. – Walgreens Boots Alliance announced that executive vice president and global chief financial officer James Kehoe will participate in a fireside chat at the Credit Suisse 27th Annual Healthcare Conference at The Phoenician, Scottsdale, Ariz. on Wednesday, November 14.
October 11, 2018 by Chain Drug Review
David King, LabCorp at Walgreens, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. and BURLINGTON, N.C. — Walgreens and LabCorp announced their mutual commitment to a significant expansion of their LabCorp at Walgreens collaboration. The two companies have agreed to open at least 600 LabCorp patient service centers at Walgreens stores across the U.S. over the next four years, inclusive of the 17 locations that have
October 11, 2018 by Chain Drug Review
Stefano Pessina, Walgreens, Walgreens Boots Alliance
Business, Featured Articles
DEERFIELD, Ill. — Walgreens Boots Alliance posted mixed fourth quarter results, as earnings beat expectations but sales fell short of projections. Adjusted net earnings for the quarter ended August 31 rose 4.5% to $1.4 billion, up 4.5% on a constant currency basis, from a year ago. Adjusted earnings per share were $1.48, up 13% on
September 20, 2018 by Chain Drug Review
Alibaba Group Holding Ltd., Alibaba’s Tmall Global platform, Boots flagship Tmall Global store, Ken Murphy, Michael Evans, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. and HANGZHOU, China — Walgreens Boots Alliance, Inc. and Alibaba Group Holding Ltd. today announced the launch of a Boots flagship store on Tmall Global, Alibaba’s B2C platform for international brands and retailers, to introduce a number of iconic Boots beauty brands to more than half a billion consumers on Alibaba’s platforms in
July 5, 2018 by Chain Drug Review
GuoDa, Ltd., Sinopharm Holding GuoDa Drugstores Co., Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. – Walgreens Boots Alliance (WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced agreement to acquire a 40% minority stake in Sinopharm Holding GuoDa Drugstores Co., Ltd. (GuoDa), a leading retail pharmacy chain in China. WBA acquired the minority stake in GuoDa through a capital increase worth
June 28, 2018 by Chain Drug Review
Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA), which entered the Dow this week, topped analysts’s forecasts in its third quarter earnings, boosted its dividend and announced a $10 billion share buyback. “I am pleased that, in what has been a challenging environment, we have again delivered solid earnings per share growth combined with healthy cash flow,” said
June 28, 2018 by Chain Drug Review
James Kehoe, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance announced that its board of directors has authorized a share repurchase program for up to $10 billion of the company’s shares. The program has no specified expiration date. The company also announced that its board of directors declared a quarterly dividend of 44 cents per share, an increase of
June 20, 2018 by Chain Drug Review
Dow Jones Industrial Average, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
NEW YORK — Walgreens Boots Alliance Inc. will replace General Electric Co. in the Dow Jones Industrial Average (DJIA) effective prior to the open of trading on Tuesday, June 26. “General Electric was an original member of the DJIA in 1896 and a member continuously since 1907,” says David Blitzer, managing director and chairman of the index committee at
March 28, 2018 by Bill Schiffner
AllianceRx Walgreens Prime, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported better-than-expected earnings and revenue on Wednesday when it announced results for the second quarter of fiscal 2018, which ended February 28. Overall, WBA earned $1.73 a share, up 27% versus a year ago. Revenue grew 12.1% to $33.02 billion. Same-store sales rose 2.4%, with comparable-pharmacy sales up
March 23, 2018 by Geoff Walden and Chain Drug Review
Lauren Brindley, No7, slideshow, Soap & Glory, Walgreens, Walgreens Beauty Differentiation, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Retail News, Slideshows
DEERFIELD, Ill. — The elevation of beauty at Walgreens continues to take the category to new heights. The retailer has just completed the second phase of the Walgreens Beauty Differentiation concept rollout, diversifying its department mix with new brands and tonics. The new experience offers an updated and stress-free beauty shopping experience with testers and
March 19, 2018 by Brian Bossetta and Chain Drug Review
George Fairweather, James Kehoe, Jim Skinner, Takeda Pharmaceutical, Walgreens Boots Alliance
2018, Issue 03-19-2018, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) recently announced the appointment of James Kehoe as the company’s executive vice president and global chief financial officer, effective June 1. Kehoe will succeed George Fairweather, who has served as WBA’s global CFO since February 2015. Fairweather has been instrumental in the formation of WBA, the subsequent integration
March 13, 2018 by Chain Drug Review
Alex Gourlay, Chain Drug Review, CVS Health, H-E-B, Kevin Hourican, Martin Otto, National Association of Chain Drug Stores, Retailer of the Year awards, slideshow, Walgreens Boots Alliance
Leading Headlines, Slideshows
NEW YORK — At a reception in Manhattan this month, Chain Drug Review honored the recipients of the publication’s Retailer of the Year Awards. In the spotlight before a throng of their retail peers and supplier partners were Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance (WBA), who was named Retailer of the Year; Kevin